Completing data — refresh the page later to see the latest
637328-69-9Cn1c(CNc2ccc(C(=N)N)cc2)nc2cc([C@@](C)(NCC(=O)O)C(=O)N3CCCC3)ccc21MAOALPSHCIBFJZ-RUZDIDTESA-NTanogitran is a small molecule drug. Tanogitran is under investigation in clinical trial NCT02254057 (Tolerability and Pharmacokinetics/-Dynamics of Single Rising Doses BIBT 986 BS in Healthy Male Subjects). Tanogitran has a monoisotopic molecular weight of 477.25 Da.
637328-69-9DTXSID70870373CHEMBL1270156UsesTanogitran is a dual inhibitor targeting Factor Xa and thrombin (thrombin), with Ki values of 26 and 2.7 nM, respectively. Tanogitran exhibits anticoagulant activity and can be used for research in thrombotic diseases[1][2].
Loading…